Phosphine-borane catalyst compounds and uses thereof
By using tertiary phosphine-borane catalyst complex to promote copolymerization of CO2 and epoxides over a wide temperature range, the problems of low activity and poor tolerance of existing catalysts are solved, and efficient and economical polymer production is achieved.
Patent Information
- Application Number
- CN202380031272.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-07-25
- Filing Date
- 2023-03-09
- Publication Date
- 2024-11-15
AI Technical Summary
Existing catalysts are low in activity in CO2 and epoxide copolymerization, expensive and intolerant to water or chain transfer agents, making it difficult to control the polymer structure and molecular weight.
Developed a tertiary phosphine-borane catalyst complex that can promote the copolymerization of CO2 and epoxides over a wide temperature range (25°C-180°C), displays excellent activity and does not contain transition metals, suitable for producing high conversion numbers polymer.
Highly active, low-cost CO2/epoxide copolymerization is achieved, enabling additional remote claw polymer chains to be generated in the presence of a bifunctional chain transfer agent, improving the structure and molecular weight control of the polymer.
Smart Images

Figure BDA0005064051050000021 
Figure BDA0005064051050000041 
Figure BDA0005064051050000071
Abstract
Description
Technical Field
[0001] This application claims the benefit of and priority to U.S. Provisional Application No. 63 / 325,451, filed on March 30, 2022, and U.S. Provisional Application No. 63 / 392,030, filed on July 25, 2022, the disclosures of which are incorporated herein by reference.
[0002] The present invention relates to novel covalently tethered phosphine-borane catalyst complexes and their use, for example, in producing polymers and block copolymers of polycarbonates and polyesters. Background Art
[0003] Polymerization catalysts are widely used in industry. Therefore, there is an interest in finding new catalyst systems that increase the commercial usability of the catalysts and allow the production of polymers with improved properties.
[0004] The copolymerization of CO2 and epoxides to produce polycarbonates is a challenging reaction. Further challenges include: (1) the polymerization is typically mediated by expensive transition metal-based catalysts, (2) the activity is typically low, typically with turnover numbers less than 1,000 / catalyst, and (3) conventional catalysts are hindered by water, alcohols, and carboxylic acids, which are often used as chain transfer agents to control polymer structure and molecular weight.
[0005] Lewis pairs consisting of unlinked (untethered) Lewis acids and Lewis bases are known for their ability to form polyalkylene carbonates from polymerized CO2 / epoxides (J. Am. Chem. Soc. 2016, 138, 35, 11117.). However, such untethered systems have three major drawbacks: (1) low activity (typically <4,000 TON), (2) low temperature capability (<100°C), and (3) intolerance to water or chain transfer agents such as alcohols.
[0006] Other relevant background can be found in Chinese patent publication CN112390819. Summary of the invention
[0007] Exemplary embodiments described herein relate to tertiary phosphine-borane catalyst complexes represented by formula (I):
[0008]
[0009] in:
[0010] B* is a Group 13 element, preferably boron or aluminum, or more preferably boron;
[0011] P constitutes a tertiary phosphine structure, where P, Y, R 3 and R 4 covalently bonded, and P is not directly bonded to more than two nitrogen atoms;
[0012] R 1 , R 2 , R 3 and R 4 wherein each is independently a hydrocarbyl group, a non-halogenated substituted hydrocarbyl group, or a heteroatom-containing group;
[0013] R 1 , R 2 , R 3 and R 4 wherein each may optionally comprise a trisubstituted borane or trisubstituted phosphine moiety;
[0014] R 1 and R 2 , R 3 and R 4 , R 1 and Y, R 3 and Y, R 1 and R 3 , and R 1 and R 2 and R 3 optionally fused to form cyclic or polycyclic rings; and
[0015] Y is a non-halogenated linking group having 1 to 50 non-hydrogen atoms, preferably 2 to 40 non-hydrogen atoms, more preferably 3 to 10 non-hydrogen atoms, preferably trimethylene, tetramethylene, pentamethylene, hexamethylene, heptamethylene, octamethylene, -CH2CH2Si(Me2)-CH2CH2- or -CH2(C6H4)-CH2-.
[0016] Detailed Description
[0017] To address the above needs, among other things, a family of catalysts based on phosphine-boranes has been developed. These catalysts can promote the copolymerization of epoxides and CO2 over a wide temperature range of 25°C-180°C. These catalysts are inexpensive and metal-free, often showing excellent activity for CHO / CO2 copolymerizations, with turnover numbers of 1,000 or greater. In the presence of bifunctional or multifunctional chain transfer agents, these catalysts can produce additional telechelic polymer chains.
[0018] definition
[0019] For purposes of this invention and the claims thereto, a new numbering scheme for the periodic table of the elements is used as described in Chemical and Engineering News, Vol. 3(5), p. 27 (1985). For example, a "Group 4 metal" is an element from Group 4 of the periodic table, such as Hf, Ti, or Zr.
[0020] The terms "substituent," "radical," "group," and "moiety" are used interchangeably.
[0021] "Conversion" is the amount of monomer converted to polymer product and is reported as mol% and is calculated based on polymer yield and the amount of monomer fed to the reactor.
[0022] "Catalyst activity" is a measure of how active a catalyst is and is reported as grams of product polymer (P) produced per mmol of catalyst (cat) used per hour (gP.mmolcat -1 .h -1 ).
[0023] The term "heteroatom" refers to any Group 13-17 element, excluding carbon. Heteroatoms may include B, Si, Ge, Sn, N, P, As, O, S, Se, Te, F, Cl, Br, and I. The term "heteroatom" may include the aforementioned elements with attached hydrogens, such as BH, BH2, SiH2, OH, NH, NH2, etc. The term "substituted heteroatom" describes a heteroatom in which one or more of these hydrogen atoms are replaced by a hydrocarbyl or substituted hydrocarbyl(s).
[0024] The term "hydrocarbon" refers to a class of compounds consisting only of the elements carbon (C) and hydrogen (H).
[0025] The term "hydrocarbyl" means a monovalent group formed by removing a hydrogen atom from a hydrocarbon.
[0026] Unless otherwise indicated, (e.g., the definition of "substituted hydrocarbyl," "substituted aryl," etc.), the term "substituted" means that at least one hydrogen atom has been replaced by at least one non-hydrogen group, such as a hydrocarbyl group, a heteroatom or a heteroatom-containing group, such as a halogen (e.g., Br, Cl, F, or I), or at least one functional group (e.g., -NR*2, -OR*, -SeR*, -TeR*, -PR*2, -AsR*2, -SbR*2, -SR*, -BR*2, -SiR*3, -GeR*3, -SnR*3, -PbR*3, wherein each R* is independently a hydrocarbyl or a halocarbyl, and two or more R* can be joined together to form a substituted or unsubstituted fully saturated, partially unsaturated or aromatic cyclic or polycyclic ring structure), or wherein at least one heteroatom has been inserted into the hydrocarbyl ring.
[0027] The term "substituted hydrocarbyl" means a hydrocarbyl group in which at least one hydrogen atom of the hydrocarbyl group has been replaced by at least one heteroatom (e.g., a halogen, such as Br, Cl, F, or I) or a heteroatom-containing group (e.g., a functional group, such as -NR*2, -OR*, -SeR*, -TeR*, -PR*2, -AsR*2, -SbR*2, -SR*, -BR*2, -SiR*3, -GeR*3, -SnR*3, -PbR*3, wherein each R* is independently a hydrocarbyl or a halogenated hydrocarbyl, and two or more R* may be joined together to form a substituted or unsubstituted fully saturated, partially unsaturated, or aromatic cyclic or polycyclic ring structure), or wherein at least one heteroatom has been inserted into the hydrocarbyl ring. The term "hydrocarbyl-substituted phenyl" means a phenyl group having 1, 2, 3, 4, or 5 hydrogen groups replaced by hydrocarbyl or substituted hydrocarbyl groups. For example, a "hydrocarbyl-substituted phenyl" group can be represented by the formula:
[0028]
[0029] Where R a , R b , R c , R d and R e Each of which can be independently selected from hydrogen, C1-C 40 Hydrocarbon or C1-C 40 Substituted hydrocarbon group, heteroatom or heteroatom-containing group (provided that R a , R b , R c , R d and R e At least one of them is not H), or R a , R b , R c , R d and R e Two or more of these may be joined together to form C4-C 62 Cyclic or polycyclic hydrocarbon ring structures, or combinations thereof.
[0030] The term "non-halogenated" excludes Group 17 elements. For example, the term "non-halogenated substituted hydrocarbyl" means a substituted hydrocarbyl group that does not contain any Group 17 elements.
[0031] The term "substituted aryl" means an aryl group having one or more hydrogen radicals replaced by a hydrocarbyl group, a substituted hydrocarbyl group, a heteroatom, or a heteroatom-containing group.
[0032] The term "substituted phenyl" means a phenyl group having one or more hydrogen groups replaced by a hydrocarbyl group, a substituted hydrocarbyl group, a heteroatom, or a group containing a heteroatom.
[0033] The terms dihydrocarbylamino and dihydrocarbylphosphino mean a nitrogen or phosphorus group bonded to two hydrocarbyl groups. Examples of suitable dihydrocarbylamino and dihydrocarbylphosphino groups may include dimethylamino, dimethylphosphino, diethylamino, diethylphosphino, and all isomers of dipropylamino, dipropylphosphino, dibutylamino, dibutylphosphino, and the like.
[0034] The term "trisubstituted borane" means a borane group having three hydrogen groups replaced with hydrocarbyl groups, substituted hydrocarbyl groups, heteroatoms, or groups containing heteroatoms.
[0035] The term "trisubstituted phosphine" or "tertiary phosphine" means a phosphine group having three hydrogen groups replaced with a hydrocarbyl group, a substituted hydrocarbyl group, a heteroatom, or a heteroatom-containing group.
[0036] The term "substituted adamantyl" means an adamantyl group having one or more hydrogen groups replaced by a hydrocarbyl, substituted hydrocarbyl, heteroatom or heteroatom-containing group. The terms "alkyloxy" and "alkoxide" mean an alkyl or aryl group bonded to an oxygen atom, such as an alkyl ether or aryl ether group / radical attached to an oxygen atom and may include groups in which the alkyl / aryl group is C1-C 10 Those of the hydrocarbon group (also referred to as the hydrocarbon oxy group). The hydrocarbon group can be straight chain, branched or cyclic. The hydrocarbon group can be saturated or unsaturated. Examples of suitable hydrocarbon oxy groups can include methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, phenoxy.
[0037] The term "aryl" or "aryl group" means an aromatic ring and substituted variants thereof, for example phenyl, 2-methyl-phenyl, xylyl, 4-bromo-xylyl. Likewise, heteroaryl means an aryl group in which a ring carbon atom (or two or three ring carbon atoms) has been replaced by a heteroatom (e.g., N, O or S). As used herein, the term "aromatic" also refers to pseudoaromatic heterocycles, which are heterocyclic substituents having properties and structures (almost planar) similar to aromatic heterocyclic ligands, but are not aromatic by definition; likewise the term aromatic also refers to substituted aromatic compounds.
[0038] The term "aralkyl" means an aryl group in which a hydrogen has been replaced by an alkyl or substituted alkyl group. For example, 3,5'-di-tert-butylphenylindenyl is an indene substituted with an aralkyl group. When an aralkyl group is a substituent on another group, it is bonded to that group through the aryl group.
[0039] The term "alkaryl" means an alkyl group in which a hydrogen has been replaced by an aryl or substituted aryl group. For example, phenethylindenyl is an indene substituted with an ethyl group bonded to a phenyl group. When an alkaryl group is a substituent on another group, it is bonded to that group through an alkyl group.
[0040] The term "ring atoms" means atoms that are part of a cyclic ring structure. According to this definition, a benzyl group has 6 ring atoms and tetrahydrofuran has 5 ring atoms.
[0041] A heterocyclic ring is a ring having heteroatoms in the ring structure, in contrast to a heteroatom-substituted ring in which hydrogens on the ring atoms are replaced by heteroatoms. For example, tetrahydrofuran is a heterocyclic ring and 4-N,N-dimethylamino-phenyl is a heteroatom-substituted ring. Other examples of heterocycles may include pyridine, imidazole, and thiazole.
[0042] The terms "hydrocarbyl radical," "hydrocarbyl group," or "hydrocarbyl" are used interchangeably and are defined to mean a group consisting only of hydrogen and carbon atoms. For example, a hydrocarbyl radical may be C1-C 100 A group, which may be linear, branched or cyclic, and may be aromatic or non-aromatic when cyclic. Examples of such groups may include, but are not limited to, alkyl groups such as methyl, ethyl, propyl (e.g., n-propyl, isopropyl, cyclopropyl), butyl (e.g., n-butyl, isobutyl, sec-butyl, tert-butyl, cyclobutyl), pentyl (e.g., isopentyl, cyclopentyl), hexyl (e.g., cyclohexyl), octyl (e.g., cyclooctyl), nonyl, decyl (e.g., adamantyl), undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, heneicosyl, docosyl, tricosyl, tetracosyl, pentacosyl, hexacosyl, heptacosyl, octacosyl, nonacosyl or triacontyl, and aryl, such as phenyl, benzyl and naphthyl.
[0043] For purposes of this specification and the appended claims, when a polymer or copolymer is referred to as comprising a monomer (a monomer present in such a polymer or copolymer is the polymerized form of the monomer). For example, when a copolymer is said to have a "caprolactone" content of 35% to 55% by weight, it is understood that the monomer (mer) units in the copolymer are derived from caprolactone in the polymerization reaction, and the derived units are present at 35% to 55% by weight based on the weight of the copolymer. A "polymer" has two or more identical or different monomer units. A "homopolymer" is a polymer having identical monomer units. A "copolymer" is a polymer having two or more monomer units that are different from each other. A "terpolymer" is a polymer having three monomer units that are different from each other. Therefore, as used herein, the definition of copolymer includes terpolymers, etc. "Different" used to refer to monomer units means that the monomer units differ from each other by at least one atom or are isomerically different. A "polylactone" is a polymer in which the monomer unit(s) in the polymer are derived from one or more lactones (wherein the lactone monomer units may be ring-opened). A "caprolactone polymer" or "caprolactone copolymer" is a polymer or copolymer comprising at least 50 mol% of one or more caprolactone derived units (eg, caprolactone, decanolide, or methylcaprolactone).
[0044] As used herein, Mn is the number average molecular weight, Mw is the weight average molecular weight, and Mz is the z-average molecular weight, wt% is the weight percent and mol% is the mole percent. Molecular weight distribution (MWD), also known as polydispersity index (PDI), is defined as Mw divided by Mn. Unless otherwise indicated, all molecular weight units (e.g., Mw, Mn, Mz) are expressed in g / mol (g mol -1 ) as unit report.
[0045] A "catalyst system" is a combination of at least one catalyst compound, an optional co-activator, an optional chain transfer agent, and an optional support material. The terms "catalyst compound" and "catalyst complex" are used interchangeably. A polymerization catalyst system is a catalyst system that can polymerize monomers into polymers.
[0046] In the description herein, the catalyst may be described as a catalyst, a catalyst compound, or a catalyst complex, and these terms may be used interchangeably.
[0047] The following abbreviations may be used herein: Me is methyl, Et is ethyl, Pr is propyl, cPr is cyclopropyl, nPr is n-propyl, iPr is isopropyl, Bu is butyl, nBu is n-butyl, iBu is isobutyl, sBu is sec-butyl, tBu is tert-butyl, p-tBu is p-tert-butyl, Hx is hexyl, Cy is cyclohexyl, Oct is octyl, Ph is phenyl, Cbz is carbazole, p-Me is p-methyl, Bz and Bn are benzyl (i.e., CH2Ph), dme is 1,2-dimethoxyethane, tol is toluene, EtOAc is ethyl acetate, TMS is trimethylsilyl, TIBAL is triisobutylaluminum, TNOAL is tri(n-octyl)aluminum, THF (also known as thf) is tetrahydrofuran, and RT is room temperature (and is 23°C unless otherwise indicated).
[0048] The term "diastereomers" is defined as non-mirror-image, non-identical stereoisomers. Diastereomers occur when two or more stereoisomers of a compound have different configurations at one or more (but not all) of the identical (related) stereocenters and are not mirror images of one another.
[0049] Phosphine-borane catalyst complex
[0050] Embodiments described herein relate to tertiary nitrogen group element-borane catalyst complexes represented by formula (I). The catalyst of formula (I) can catalyze the polymerization of one or more epoxides and one or more of CO2, COS and CS2.
[0051] Exemplary embodiments described herein relate to tertiary phosphine-borane catalyst complexes represented by formula (I):
[0052]
[0053] in:
[0054] B* is a Group 13 element, preferably boron or aluminum, or more preferably boron;
[0055] P constitutes a tertiary phosphine structure, where P, Y, R 3 and R 4 covalently bonded, and P is not directly bonded to more than two nitrogen atoms;
[0056] R 1 , R 2 , R 3 and R 4 wherein each is independently a hydrocarbyl group, a non-halogenated substituted hydrocarbyl group, or a heteroatom-containing group;
[0057] R 1 , R 2 , R 3 and R 4wherein each may optionally comprise a trisubstituted borane or trisubstituted phosphine moiety;
[0058] R 1 and R 2 , R 3 and R 4 , R 1 and Y, R 3 and Y, R 1 and R 3 , and R 1 and R 2 and R 3 optionally fused to form cyclic or polycyclic rings; and
[0059] Y is a non-halogenated linking group having 1 to 50 non-hydrogen atoms, preferably 2 to 40 non-hydrogen atoms, more preferably 3 to 10 non-hydrogen atoms, preferably trimethylene, tetramethylene, pentamethylene, hexamethylene, heptamethylene, octamethylene, -CH2CH2Si(Me2)-CH2CH2- or -CH2(C6H4)-CH2-.
[0060] In some embodiments of Formula (I), R 1 , R 2 , R 3 , R 4 and Y does not contain a Group 2 to 12 metal. In some embodiments of Formula (I), R 1 , R 2 , R 3 , R 4 and Y does not contain a Group 3 to 11 transition metal.
[0061] In some embodiments, no phosphorus atom is directly bonded to more than two nitrogen atoms.
[0062] In some embodiments of Formula (I), R 3 and / or R 4 is a secondary alkyl group, a tertiary alkyl group, or R 3 and R 4 Fused to form cyclic or polycyclic rings.
[0063] In some embodiments of Formula (I), R 1 , R 2 , R 3 and R 4 is a hydrocarbon containing 0, 1 or 2 B* moieties and 0, 1 or 2 P moieties.
[0064] In some embodiments of Formula (I), R 1 , R 2 , R 3 and R 4Contains heteroatoms to form heteroatom-C or heteroatom-P or heteroatom-B* bonds.
[0065] In some embodiments of Formula (I), each R 1 , R 2 , R 3 and R 4 are independently alkyl, substituted alkyl, aryl or substituted aryl groups, such as C1-C 50 (e.g. C2-C 30 , for example C3-C 20 ) alkyl, C1-C 50 (e.g. C2-C 30 , for example C3-C 20 ) substituted alkyl, C5-C 50 (e.g. C6-C 30 , for example C6-C 20 ) aryl, or C5-C 50 (e.g. C6-C 30 , for example C6-C 20 ) substituted aryl group.
[0066] Alternatively, in some embodiments of Formula (I), R 1 , R 2 , R 3 and R 4 are independently selected from methyl, ethyl, propyl, butyl, pentyl, neopentyl, adamantyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, heneicosyl, docosyl, tricosyl, tetracosyl, pentacosyl, hexacosyl, heptacosyl, octacosyl, nonacosyl, triacontyl, phenyl, substituted phenyl (e.g., methylphenyl and dimethylphenyl), benzyl, substituted benzyl (e.g., methylbenzyl), naphthyl, cyclohexyl, cyclohexenyl, methylcyclohexyl, norbornyl, substituted norbornyl, and isomers thereof.
[0067] In some embodiments of Formula (I), R 1 and R 2 , R 3 and R 4 , R 1 and Y, R 3 and Y, R 1 and R 3 , and R 1 and R 2 and R 3 One or more pairs of the amines may be fused and may form a saturated or aromatic cyclic or polycyclic group.
[0068] In some embodiments of Formula (I), R 1 , R 2 , R 3 and R 4 One or more of the catalyst compositions comprises one or more catalyst compositions selected from the catalyst composition represented by formula (I).
[0069] In some embodiments of formula (I), each Y is independently a hydrocarbon group or a substituted hydrocarbon group, a group containing a heteroatom of Group 14, 15, 16 or 17, or a substituted heteroatom of Group 13, 14, 15, 16 or 17 (e.g., a silyl group, a substituted silyl group, an oxygen group, a sulfur group, a nitrogen group or a phosphine group), such as an alkyl group, a substituted alkyl group, an aryl group or a substituted aryl group, such as a C1-C 50 (e.g. C2-C 30 , for example C3-C 20 ) alkyl, C1-C 50 (e.g. C2-C 30 , for example C3-C 20 ) substituted alkyl, C5-C 50 (e.g. C6-C 30 , for example C6-C 20 ) aryl, or C5-C 50 (e.g. C6-C 30 , for example C6-C 20 ) substituted aryl group.
[0070] Alternatively, in some embodiments of Formula (I), each Y is independently selected from methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, heneicosyl, docosyl, tricosyl, tetracosyl, pentacosyl, hexacosyl, heptacosyl, octacosyl, nonacosyl, triacontyl, phenylene, substituted phenylene (e.g., 1,2-phenylene, 1,3-phenylene, 1,4-phenylene, 1,8-naphthalene, methylphenylene and dimethylphenylene), benzyl, substituted benzyl (e.g., methylbenzyl), naphthyl, cyclohexyl, cyclohexenyl, methylcyclohexyl, norbornyl, substituted norbornyl, and isomers thereof.
[0071] In some embodiments of Formula (I), each Y is independently -O-, (-CH2-)n, wherein n is 1 to 5, alternatively n is 2 to 30, alternatively n is 3 to 12 (alternatively n is 1, such as -CH2-), -CR2-, -SiR2-, -GeR2-, -NR- (wherein each R is independently methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, heneicosyl, docosyl, tricosyl, tetracosyl, pentacosyl, hexacosyl, heptacosyl, octacosyl, nonacosyl, triacontyl, phenyl, substituted phenyl (e.g., methylphenyl and dimethylphenyl), benzyl, substituted benzyl (e.g., methylbenzyl), naphthyl, cyclohexyl, cyclohexenyl, methylcyclohexyl, norbornyl, or substituted norbornyl.
[0072] In some embodiments of formula (I), Y is a bridging group containing at least one element of Group 13, 14, 15, 16 or 17 (particularly boron) or an element of Group 14, 15, 16 or 17. Examples of suitable bridging groups include P(=S)R*, P(=Se)R*, P(=O)R*, R*2C, R*2Si, R*2Ge, R*2CCR*2, R*2CCR*2CR*2, R*2CCR*2CR*2CR*2, R*C=CR*, R*C=CR*CR*2, R*2CCR*=CR*CR*2, R*C=CR*CR*=CR*, R*C=CR*CR*2CR*2, R*2CSiR*2, R*2SiSiR*2, R*2 2SiOSiR*2, R*2CSiR*2CR*2, R*2SiCR*2SiR*2, R*C=CR*SiR*2, R*2CGeR*2, R*2GeGeR*2, R*2CGeR*2CR*2, R*2Ge CR*2GeR*2, R*2SiGeR*2, R*C=CR*GeR*2, R*B, R*2C–BR*, R*2C–BR*–CR*2, R*2C–O–CR*2, R*2CR*2C–O–CR*2CR*2 , R*2C–O–CR*2CR*2, R*2C–O–CR*=CR*, R*2C–S–CR*2, R*2CR*2C–S–CR*2CR*2, R*2C–S–CR*2CR*2, R*2C–S–CR*=C R*, R*2C–Se–CR*2, R*2CR*2C–Se–CR*2CR*2, R*2C–Se–CR*2CR*2, R*2C–Se–CR*=CR*, R*2C–N=CR*, R*2C–NR*–CR *2, R*2C–NR*–CR*2CR*2, R*2C–NR*–CR*=CR*, R*2CR*2C–NR*–CR*2CR*2, R*2C–P=CR*, R*2C–PR*–CR*2, O, S, Se, Te, NR*, PR*, AsR*, SbR*, OO, SS, R*N-NR*, R*P-PR*, OS, O-NR*, O-PR*, S-NR*, S-PR*, and R*N-PR*, wherein R* is hydrogen or contains C1-C 20R* may be a substituted hydrocarbon, substituted hydrocarbon, halogenated hydrocarbon, substituted halogenated hydrocarbon, silylcarbyl or germylcarbyl substituent, and optionally two or more adjacent R* may be joined to form a substituted or unsubstituted, saturated, partially unsaturated or aromatic, cyclic or polycyclic substituent. Preferred examples of the bridging group Y include CH2, CH2CH2, SiMe2, SiPh2, SiMePh, Si(CH2)3, Si(CH2)4, O, S, NPh, PPh, NMe, PMe, NEt, NPr, NBu, PEt, PPr, Me2SiOSiMe2 and PBu. In a preferred embodiment of the invention, in any embodiment of any formula described herein, Y is represented by the formula ER y 2 or (ER y 2)2 represents, where E is C, Si or Ge, and each R y are independently hydrogen, halogen, C1-C 20 A hydrocarbon group (e.g., methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl or dodecyl) or a C1-C 20 substituted hydrocarbon group, and both R y Cyclic structures may be formed, including aromatic, partially saturated or saturated cyclic or fused ring systems. Preferably, Y is a bridging group comprising carbon or silicon, such as a dialkylsilyl group, preferably Y is selected from CH2, CH2CH2, C(CH3)2, SiMe2, Me2Si-SiMe2, cyclotrimethylenesilyl (Si(CH2)3), cyclopentamethylenesilyl (Si(CH2)5) and cyclotetramethylenesilyl (Si(CH2)4).
[0073] For complex 1, R 1 and R 2 It forms a fused ring with boron, i.e. 9-borahertabicyclo (3.3.1) nonane, R 3 =R 4 = tert-butyl, Y = trimethylene.
[0074] For complex 2, R 1 and R 2 It forms a fused ring with boron, i.e. 9-borahertabicyclo (3.3.1) nonane, R 3 =R 4 = tert-butyl, Y = pentamethylene.
[0075] For complex 3, R 1 and R 2 It forms a fused ring with boron, i.e. 9-borahertabicyclo (3.3.1) nonane, R 3 =R 4 =1-adamantyl, Y =pentamethylene.
[0076] For complex 4, R 1 and R 2 It forms a fused ring with boron, i.e. 9-borahertabicyclo (3.3.1) nonane, R 3 and R 4 It forms a fused ring with phosphine, namely 9-phosphabicyclo(3.3.1)nonane, where Y = pentamethylene.
[0077] Specific examples of catalyst complexes useful herein are shown below:
[0078]
[0079] Additional catalyst structures of formula (I) include:
[0080]
[0081]
[0082]
[0083]
[0084] Catalyst compounds particularly useful in the present invention include one or more of the following: Complex 2, designated "(3-(9-borabicyclo[3.3.1]nonan-9-yl)pentyl)di-tert-butylphosphane", Complex 3, designated "(5-(9-borabicyclo[3.3.1]nonan-9-yl)pentyl)di(adamantan-1-yl)phosphane", which are of particular interest.
[0085] In alternative embodiments, one phosphine-borane catalyst complex is used in any of the methods described herein, eg, the catalyst complexes are not different. For purposes of the present invention, one catalyst complex is considered different if it differs from another by at least one atom.
[0086] In some embodiments, there are two or more different catalyst complexes in the catalyst system used herein. In some embodiments, there are two or more different catalyst complexes in the reaction zone where the method (one or more) described herein occurs. Optionally, the same initiator is used for the compound, however, two different initiators can be used in combination.
[0087] The two catalyst complexes can be used in any ratio. The preferred molar ratio of (A) catalyst complex to (B) catalyst complex falls within the range of (A:B) of 1:1000 to 1000:1, alternatively 1:100 to 500:1, alternatively 1:10 to 200:1, alternatively 1:1 to 100:1, and alternatively 1:1 to 75:1, and alternatively 5:1 to 50:1. The specific ratio selected will depend on the exact complex selected, the initiation method, and the desired end product. In a particular embodiment, when two catalysts are used, the available molar percentages are 10 to 99.9% A to 0.1 to 90% B, alternatively 25 to 99% A to 0.5 to 50% B, alternatively 50 to 99% A to 1 to 25% B, and alternatively 75 to 99% A to 1 to 10% B based on the molecular weight of the catalyst.
[0088] General method for preparing phosphine-borane catalyst compounds
[0089] Method A: reacting phosphine chloride with an alkenyl MgBr reagent in THF or diethyl ether at -30°C, followed by stirring at 25°C to 60°C for 24-96 hours to provide an alkenyl dialkyl nitrogen group element, which can then be reacted with hydridoborane in THF or dichloromethane at 20°C to 65°C for 24-96 hours to form a catalyst complex. Method B: reacting a secondary nitrogen group element with nBuLi (or MeLi) in THF or diethyl ether at -30°C, followed by stirring at 25°C to 60°C for 24-96 hours to provide an alkenyl dialkyl phosphine, which can then be reacted with hydridoborane in THF or dichloromethane at 20°C to 65°C for 24-96 hours to form a catalyst complex.
[0090] Method A
[0091]
[0092] Chain transfer agent
[0093] Typically, a chain transfer agent (CTA) allows polymerization to produce additional polymer chains. CTAs can be used to produce additional polymer chains. CTAs can also be used to control molecular weight. CTAs that can be used with the catalyst complex can include water, alcohols (e.g., diols), carboxylic acids (e.g., dicarboxylic acids), carboxylic acid esters / salts, or thiol groups. Examples include: water, ethanol, methanol, 1,4-benzenedimethanol, 1,2-trans-dihydroxycyclohexane, and terephthalic acid. CTAs can also be oligomers or polymers characterized by one or more than one alcohol or carboxylic acid end groups.
[0094] In embodiments, bifunctional chain transfer agents (e.g., polyols) may be used with the catalyst complexes described herein to produce additional telechelic polymers (e.g., polyols) having multiple functional groups. Useful bifunctional chain transfer agents include 1,4-benzenedimethanol, 1,2-trans-dihydroxycyclohexane, terephthalic acid, or telechelic polyols.
[0095] Examples of Chain Transfer Agents (CTA):
[0096]
[0097] in
[0098] Indicates an oligomer or polymer containing one or more OH groups
[0099] Co-activator
[0100] A co-activator may be used with the catalyst complex. The co-activator is typically a Lewis acid or Lewis base that does not itself catalyze the polymerization of CO2 / epoxide or lactone or lactide. The co-activator may be used in conjunction with an initiator to form an activated catalyst complex. In some embodiments, the co-activator may be premixed with the catalyst complex prior to introduction into the reaction zone or may be introduced into the reaction zone separately. Compounds that may be used as co-activators include, for example, halogenated and bis(triphenylphosphine)iminium halides, or triethylborane, tricyclohexylborane, tri-n-hexylborane, and the like.
[0101] Aggregation methods
[0102] In embodiments herein, the invention relates to polymerization processes wherein one or more epoxide monomers and one or more of CO2, COS, CS2 are contacted with one or more catalyst compositions as described above to form an oxygen-containing polymer, such as a polyalkylene carbonate, polyalkylene ether carbonate, or polyether.
[0103]
[0104] In embodiments herein, the invention is directed to a polymerization process wherein carbon dioxide is copolymerized with vinyl cyclohexene dioxide or limonene dioxide to form a polyalkylene carbonate comprising pendant cyclic carbonate groups as shown below.
[0105]
[0106] In embodiments herein, the invention is directed to polymerization processes wherein one or more of one or more epoxide monomers and cyclic anhydrides are contacted with one or more catalyst compositions as described above to form poly(epoxide)(cyclic anhydride), poly(epoxide)(cyclic anhydride)ether, or polyether.
[0107]
[0108] In embodiments herein, the invention relates to a polymerization process wherein one or more lactone or lactide monomers are contacted with a catalyst compound as described above to form a polylactide polymer such as polycaprolactone, polydecanoic acid, polymethylcaprolactone, polylactide, or copolymers thereof.
[0109] In embodiments herein, the invention relates to a polymerization process wherein one or more lactone monomers and optionally one or more caprolactone monomers are contacted with one or more catalyst compounds as described above to form a polylactone polymer such as polycaprolactone, polydecanoic acid, polymethylcaprolactone or copolymers thereof, and thereafter the polymer is contacted with one or more epoxide monomers, one or more of CO2, COS, CS2, cyclic anhydrides and one or more catalyst compositions as described above to form a copolymer such as a random copolymer, a gradient copolymer or a block copolymer.
[0110] Embodiments of the present technological advances are directed to methods of producing polymers comprising contacting a catalyst composition represented by formula (I) with one or more caprolactones to obtain polycaprolactones.
[0111] Epoxide monomers useful herein include epoxides, substituted epoxides, and isomers thereof. Examples of epoxides include, but are not limited to, cyclohexene oxide, methylcyclohexene oxide, dimethyl cyclohexene oxide, ethyl cyclohexene oxide, vinyl cyclohexene oxide, vinyl cyclohexene dioxide, limonene oxide, limonene dioxide, ethylene oxide, propylene oxide, butylene oxide, 1,2-dimethylethylene oxide, pentyl oxide, hexyl oxide, heptane oxide, octane oxide, epichlorohydrin, glycidyl methyl ether, glycidyl ethyl ether, glycidyl n-butyl ether, glycidyl isobutyl ether, glycidyl allyl ether, glycidyl 2-ethylhexyl ether, glycidyl benzyl ether, glycidyl phenyl ether, and norbornene oxide.
[0112] The cyclic anhydride monomers useful herein include succinic anhydride, maleic anhydride, methylsuccinic anhydride, citraconic anhydride, phenylsuccinic anhydride, glutaric anhydride, diglycolic anhydride, pimelic anhydride, phthalic anhydride, cyclohexene anhydride, cyclohexane anhydride, cyclopentane anhydride, and carbolic anhydride.
[0113] Exemplary epoxide monomers include cyclohexene oxide and vinyl cyclohexene oxide and their respective homologs and derivatives.
[0114] In an embodiment of the present invention, epoxide monomers (eg, cyclohexene oxide and vinyl cyclohexene oxide) are combined with one or more of CO2, COS, CS2 (eg, CO2).
[0115] Lactone monomers include lactones and substituted lactones such as methyl caprolactone and decanolactone. Lactones include caprolactone.
[0116] A lactone is a cyclic carboxylic acid ester containing a 1-oxacycloalkane-2-one structure (—C(═O)—O—), and a “substituted lactone” is a lactone having one or more hydrogen groups substituted by a hydrocarbon group, a substituted hydrocarbon group, a heteroatom or a heteroatom-containing group and / or having one or more ring atoms substituted by a heteroatom.
[0117] Lactones useful herein include caprolactone, substituted caprolactones (e.g., alkyl caprolactones, wherein the alkyl group is C1-C 30 alkyl), such as methyl caprolactone), valerolactone, propiolactone, butyrolactone, caprolactone, decanolactone.
[0118] The monomers and comonomers used herein may be linear, branched or cyclic, and if cyclic may be strained or unstrained, monocyclic or polycyclic, and may optionally include heteroatoms and / or one or more functional groups.
[0119] polymerization
[0120] Solution polymerization is a polymerization process in which the polymer is dissolved in a liquid polymerization medium (e.g., an inert solvent or monomer(s) or a blend thereof). Solution polymerization is typically homogeneous. Homogeneous polymerization is a polymerization in which the polymer product is dissolved in the polymerization medium (e.g., 80% by weight or more, 90% by weight or more, or 100% of the polymer product is dissolved in the reaction medium). Such a system is preferably not turbid as described in Oliveira, JV et al. (2000) Ind. Eng, Chem. Res., Vol. 29, p. 4627.
[0121] Bulk polymerization refers to a polymerization process in which the monomers and / or comonomers being polymerized serve as solvents or diluents, with little or no use of inert solvents as solvents or diluents. A small portion of the inert solvent may serve as a carrier for the catalyst and scavenger. Bulk polymerization systems typically contain less than 25% by weight of an inert solvent or diluent, preferably less than 10% by weight, preferably less than 1% by weight, preferably 0% by weight.
[0122] The polymerization process of the present invention may be carried out in any manner known in the art. Any suspension, homogeneous, bulk or solution polymerization process known in the art may be used. Such a process may be operated in batch, semi-batch or continuous mode. Homogeneous polymerization processes are generally useful, such as homogeneous polymerization processes in which at least 90% by weight of the product is soluble in the reaction medium. Bulk homogeneous processes are also useful, such as processes in which the monomer concentration in all feeds to the reactor is 70% by volume or greater. Alternatively, no solvent or diluent is present or added to the reaction medium (except for small amounts used as carriers for the catalyst system or other additives, or amounts typically found with the monomers).
[0123] Suitable diluents / solvents for the polymerization include inert liquids. Examples include straight and branched chain hydrocarbons such as isobutane, butane, pentane, isopentane, hexane, isohexane, heptane, octane, dodecane and mixtures thereof; cyclic and alicyclic hydrocarbons such as cyclohexane, cycloheptane, methylcyclohexane, methylcycloheptane and mixtures thereof, such as commercially available (Isopar TM fluid); perhalogenated hydrocarbons, such as perfluorinated C 4-10 Alkanes, chlorobenzenes, and aromatic and alkyl-substituted aromatic compounds, such as benzene, toluene, mesitylene and xylene. Suitable solvents also include liquid olefins, which can act as monomers or comonomers, including ethylene, propylene, 1-butene, 1-hexene, 1-pentene, 3-methyl-1-pentene, 4-methyl-1-pentene, 1-octene, 1-decene and mixtures thereof. In a preferred embodiment, aliphatic hydrocarbon solvents are used as solvents, such as isobutane, butane, pentane, isopentane, hexane, isohexane, heptane, octane, dodecane and mixtures thereof; cyclic and alicyclic hydrocarbons, such as cyclohexane, cycloheptane, methylcyclohexane, methylcycloheptane and mixtures thereof. In another embodiment, the solvent is not aromatic, preferably aromatic compounds are present in the solvent with less than 1 wt %, preferably less than 0.5 wt %, preferably less than 0 wt %, based on the weight of the solvent. Suitable diluents / solvents for polymerization also include polar, heteroatom-containing liquids such as tetrahydrofuran, dichloromethane, dimethoxyethane.
[0124] In a preferred embodiment, the feed concentration of monomers and comonomers used in the polymerization is 60 volume % solvent or less, preferably 40 volume % or less, or preferably 20 volume % or less, based on the total volume of the feed stream, or preferably no solvent. Preferably, the polymerization is run as a bulk process.
[0125] Preferred polymerizations can be run at any temperature and / or pressure suitable for obtaining the desired polymer. Typical temperatures and / or pressures include temperatures in the range of about 0°C to about 300°C, preferably about 20°C to about 200°C, preferably about 35°C to about 150°C, preferably about 40°C to about 130°C, preferably about 45°C to about 120°C, and pressures in the range of about 0.35 MPa to about 10 MPa, preferably about 0.45 MPa to about 6 MPa, or preferably about 0.5 MPa to about 4 MPa.
[0126] In a typical polymerization, the reaction run time is up to 4,320 minutes, preferably in the range of about 3 to 1,440 minutes, or preferably about 10 to 240 minutes.
[0127] In alternative embodiments, the activity of the catalyst is at least 50 g / g catalyst, preferably 500 or more g / g catalyst, preferably 5,000 or more g / g catalyst, preferably 50,000 or more g / g catalyst. In alternative embodiments, the conversion of the monomer is at least 5%, based on the polymer yield and the weight of the monomer entering the reaction zone, preferably 10% or more, preferably 30% or more, preferably 50% or more, preferably 80% or more.
[0128] Sequential monomer addition polymerization allows the synthesis of multi-block copolymers, which are useful in adhesives, elastomers, and thermoplastics, among others.
[0129] In alternative embodiments, the catalyst complexes described herein can be used to prepare block copolymers, typically diblock and triblock copolymers. This can be accomplished by sequentially adding monomers to the same catalyst complex or by sequential polymerization reactions using different catalysts. This can also be accomplished by sequentially adding monomers to multiple catalyst complexes or by adding new catalyst complexes and monomers in the same or different reaction zones.
[0130] In alternative embodiments, the catalyst complexes as described herein can be used in combination with non-nitrogen group element-borane catalysts such as metal catalyst compounds (e.g., tin 2-ethylhexanoate) to produce block copolymers. For example, such metal catalyst compounds can produce telechelic polyols of polylactones (e.g., polycaprolactone) in the first stage of polymerization. The catalyst can then be introduced in the second stage of polymerization, which can achieve copolymerization with epoxides / CO2, COS, CS2. Epoxides can be introduced in the first or second stage.
[0131] In a preferred embodiment, the polymerization reaction of the catalyst composition represented by formula (I):
[0132] 1) at a temperature of 0°C to 300°C (preferably 20°C to 200°C, preferably 35°C to 150°C, preferably 40°C to 130°C);
[0133] 2) under a pressure of atmospheric pressure to 10 MPa (preferably 0.35 to 10 MPa, preferably 0.45-6 MPa, preferably 0.5-4 MPa);
[0134] 3) in a solvent, or can be carried out in neat epoxide (without or with added solvents such as dichloromethane or toluene);
[0135] 4) The polymerization reaction is preferably carried out under an inert atmosphere such as nitrogen or argon;
[0136] 5) occurs in a reaction zone; and
[0137] 6) Having a catalyst composition turnover number of 100 or greater (preferably at least 200, preferably at least 500, preferably at least 5,000).
[0138] In a preferred embodiment, the catalyst composition used in the polymerization comprises no more than one catalyst complex. A "reaction zone" (also referred to as a "polymerization zone") is a container, such as a batch reactor, in which polymerization occurs. When multiple reactors are used in a series or parallel configuration, each reactor is considered to be a separate polymerization zone. For multistage polymerization in both batch reactors and continuous reactors, each polymerization stage is considered to be a separate polymerization zone. In a preferred embodiment, polymerization occurs in one reaction zone. Room temperature is 23°C unless otherwise stated.
[0139] If desired, other additives may also be used in the polymerization, such as one or more scavengers, promoters, modifiers, reducing agents, oxidizing agents, hydrogen, alkyl aluminum, silanes, or chain transfer agents.
[0140] Polymer properties
[0141] Typically, the polymers produced herein have an Mw of 500 to 3,000,000 g / mol (preferably 1,000 to 750,000 g / mol, preferably 10,000 to 500,000 g / mol) as determined by LT THF GPC-ID (see procedure below).
[0142] Typically, the polymers produced herein have a Mw / Mn of greater than 1 to 40 (alternatively 1.01 to 20, alternatively 1.1 to 10, alternatively 1.3 to 5, 1.4 to 4, alternatively 1.5 to 3) as determined by GPC methods.
[0143] In a preferred process, the polymerization catalysts described herein are used to produce polycarbonate block copolymers.
[0144] Blends and end uses
[0145] In another embodiment, the polymer produced herein is combined with one or more additional polymers before being formed into an article. Other useful polymers include polyethylene, isotactic polypropylene, highly isotactic polypropylene, syndiotactic polypropylene, random copolymers of propylene and ethylene and / or butane and / or hexene, polybutene, ethylene vinyl acetate, LDPE, LLDPE, HDPE, ethylene vinyl acetate, ethylene methacrylate, copolymers of acrylic acid, polymethyl methacrylate or any other polymer that can be polymerized by a high pressure free radical process, polyvinyl chloride, polybutene-1, isotactic polybutene, ABS resin, ethylene-propylene rubber (EPR), sulfurized EPR, EPDM, block copolymers, styrene block copolymers, polyamides, polycarbonates, PET resins, crosslinked polyethylene, copolymers of ethylene and vinyl alcohol (EVOH), polymers of aromatic monomers such as polystyrene, poly-1 esters, polyacetals, polyvinylidene fluoride, polyethylene glycol and / or polyisobutylene.
[0146] In a preferred embodiment, the polymer is present in the above blend at 10 wt% to 99 wt%, preferably 20 wt% to 95 wt%, even more preferably at least 30 wt% to 90 wt%, even more preferably at least 40 wt% to 90 wt%, even more preferably at least 50 wt% to 90 wt%, even more preferably at least 60 wt% to 90 wt%, even more preferably at least 70 wt% to 90 wt%, based on the weight of the polymer in the blend.
[0147] The blends described above can be produced by mixing the polymer of the invention with one or more polymers (as described above), by connecting reactors together in series to make reactor blends, or by using more than one catalyst in the same reactor to produce multiple polymer species. The polymers can be mixed together before being placed in the extruder or can be mixed in the extruder.
[0148] The blend can be formed as follows: using conventional equipment and methods, such as by dry blending the individual components and then melt mixing in a mixer, or by mixing the components together directly in a mixer, such as a Banbury mixer, a Haake mixer, a Brabender internal mixer, or a single screw or twin screw extruder, which can include a compounding extruder and a side arm extruder used directly downstream of the polymerization process, which can include powders or pellets of the blended resins at the film extruder hopper. In addition, additives can be included in the blend, in one or more components of the blend, and / or in a product formed from the blend, such as a film, as desired. Such additives are well known in the art and may include, for example, fillers, antioxidants (e.g., hindered phenols such as IRGANOX™ 1010 or IRGANOX™ 1076 available from Ciba-Geigy), phosphites (e.g., IRGAFOS™ 168 available from Ciba-Geigy), anti-stick additives, tackifiers such as polybutene, terpene resins, aliphatic and aromatic hydrocarbon resins, alkali metal and glyceryl stearates, and hydrogenated rosin, UV stabilizers, heat stabilizers, anti-blocking agents, release agents, antistatic agents, pigments, colorants, dyes, waxes, silica, fillers, talc, and the like.
[0149] Any of the above polymers and compositions and optional additives (antioxidants, colorants, dyes, stabilizers, fillers, etc.) can be used in various end-use applications produced by methods known in the art. Exemplary end uses are articles formed by molding techniques such as injection molding or blow molding, extrusion coating, foaming, casting, and combinations thereof.
[0150] experiment
[0151] GPC Method
[0152] The instruments used are as follows:
[0153] Agilent 1260 Infinity II Multi-Detector GPC / SEC System;
[0154] Pump – Quadruple pump (up to four different solvents);
[0155] Operating temperature range: 30°C-60°C; and
[0156] Detector:
[0157] Differential refractive index (DRI) detector at 658 nm,
[0158] Viscometer detector (inlet pressure and differential pressure),
[0159] Light scattering (LS) detector at 658 nm (dual channel MALS: 90° and 15°), and
[0160] • UV diode array detector (up to eight wavelengths from 190nm-950nm).
[0161] All detectors are mounted vertically in series: UV to light scattering to refractive index to viscometer.
[0162] Agilent multi-detector GPC / SEC instrument control and data analysis software suite was used.
[0163] The chromatographic conditions were as follows:
[0164] Column: 2×Plgel 5μm Mixed-C, 7.5×300mm, with guard column;
[0165] Diluent: tetrahydrofuran (stabilized with 250 ppm BHT);
[0166] Operating temperature: 40℃;
[0167] Injection volume: 25 μL;
[0168] Running flow rate: 1.0 mL / min; and
[0169] Run time: 36 minutes with 3 minutes post run time.
[0170] Detector calibration was performed by using a traceable 50,000 g / mole polystyrene narrow standard. Column calibration was performed by using 23 traceable polystyrene narrow standards ranging from 200-4,000,000 g / mole.
[0171] Material
[0172] Cyclohexene oxide (CHO), butylene oxide (BO), propylene oxide (PO), dichloromethane (DCM), caprolactone (CL) and decanolactone (DL) were purchased from Aldrich and purified by distillation on CaH2 under N2. Benzenedimethanol (PDM) and trans-1,2-dihydroxycyclohexane (DHCH) were purchased from Aldrich and recrystallized from anhydrous toluene. Methyl caprolactone (MCL) was synthesized according to the literature procedure (Macromolecules 2011, Vol. 44, pp. 8537–8545). 9-phosphabicyclononane (isomers), commonly referred to as phobane, was purchased from Strem. Phobane isomers can be separated as described in J.Am.Chem.Soc. 2009, Vol. 131, pp. 3078-3092 before use. 4,8-Dimethyl-2-phosphabicyclo[3.3.1]nonane (isomers) was purchased from Strem.
[0173]
[0174] Phobane[3.3.1]Phobane[4.2.1] Example
[0175] synthesis: Allyl di-tert-butylphosphane
[0176]
[0177] Allyl di-tert-butylphosphane (C 11 H 23 P). To a solution of di-tert-butylchlorophosphane (5.00 g, 27.7 mmol) in Et2O (200 ml) was slowly added a 1M Et2O solution of allylmagnesium bromide (29.1 ml, 29.1 mmol) at -20°C. The reaction mixture was then stirred at ambient temperature for 24 minutes. The reaction was then quenched by an aqueous solution of NH4Cl (0.5 ml). After stirring for 30 minutes, the reaction was dried over MgSO4 for 30 minutes. All solids were removed by filtration over celite and washed with hexane. The solvent was removed under vacuum. The product was distilled under vacuum and obtained as a clear oil (2.65 g, 51%). 1 HNMR (500MHz, CDCl3) δ6.08–5.72(m,1H),5.06(d,J=17.0Hz,1H),4.96(d,J=9.9Hz,1H),2.40–2.14(m,2H),1.14(d,J=11.1Hz,18H). 13 C NMR (126MHz, CDCl3) δ 138.38 (d, J = 16.7Hz), 115.00 (d, J = 10.9Hz), 31.61 (d, J = 21.8Hz), 29.68 (d, J = 13.1Hz), 26.88 (d, J = 21.0Hz). 31 P NMR (162 MHz, CDCl3) δ 28.84.
[0178] synthesis: (3-(9-Borabicyclo[3.3.1]non-9-yl)propyl)di-tert-butylphosphane
[0179]
[0180] (3-(9-borahertabicyclo[3.3.1]non-9-yl)propyl)di-tert-butylphosphane (C 19 H 38PB). Allyl di-tert-butylphosphane (1.27 g, 6.81 mmol) and 9-BBN (0.85 g, 6.95 mmol) were mixed in dichloromethane (10 ml) and stirred at room temperature for 16 hours. All solvents were then removed under vacuum. The crude product was stirred in pentane (10 ml) for 30 minutes. The pure product (2.10 g, 100%) was obtained by filtration (as a white solid) and washed with pentane. 1 H NMR (500MHz, CDCl3) δ2.05–1.87(m,6H),1.85–1.64(m,8H),1.63–1.48(m,2H ),1.33(d,J=11.2Hz,18H),1.13–1.05(m,2H),0.90(dt,J=16.6,6.6Hz,2H). 13 C NMR (126 MHz, CDCl3) δ34.83 (d, J = 3.6 Hz), 34.17 (d, J = 6.4 Hz), 30.42 (d, J = 3.6 Hz), 26.74, 25.37, 24.52, 22.08 (d, J = 26.0 Hz). 31 P NMR (162 MHz, CDCl3) δ 36.29. 11 B NMR (128 MHz, CDCl3) δ 11.37.
[0181]
[0182] Di-tert-butyl (pent-4-en-1-yl) phosphane (C 13 H 27 P). To a solution of di-tert-butylphosphane (1.31 g, 8.87 mmol) in THF (10 ml) was added at -30°C. n A 1.6 M hexane solution of BuLi (5.77 ml, 9.24 mmol) was added. The solution was then stirred at room temperature for 30 minutes. The reaction was cooled down to -30 °C again and then 5-bromopent-1-ene (1.47 g, 9.86 mmol) was slowly added. The mixture was then stirred at room temperature for 16 hours. All solvents were then removed under vacuum. The crude product was stirred in pentane (10 ml) for 30 minutes. The pure product was obtained by vacuum distillation at 90 °C to give a colorless oil. 1 H NMR (500MHz, CDCl3) δ5.91–5.73(m,1H),5.16–4.75(m,2H),2.17(q,J=7.2H z, 2H), 1.63 (q, J = 7.9Hz, 2H), 1.48–1.26 (m, 2H), 1.14 (s, 9H), 1.12 (s, 9H). 13C NMR (126MHz, CDCl3) δ 138.54, 114.73, 35.40 (d, J = 13.4Hz), 31.17 (d, J = 19.8Hz), 29.71 (d, J = 25.8Hz), 29.63 (d, J = 13.3Hz), 20.45 (d, J = 19.5Hz). 31 P NMR (162 MHz, CDCl3) δ 28.38.
[0183]
[0184] (5-(9-borabicyclo[3.3.1]non-9-yl)pentyl)di-tert-butylphosphane (C 21 H 42 BrPB). Di-tert-butyl(pent-4-en-1-yl)phosphane (0.94 g, 4.40 mmol) and 9-BBN (0.55 g, 4.49 mmol) were mixed in dichloromethane (10 ml) and stirred at room temperature for 16 hours. All solvents were then removed under vacuum. The crude product was stirred in pentane (10 ml) for 30 minutes. The pure product (1.48 g, 100%) was obtained by filtration (as a yellow solid) and washed with pentane. 1 H NMR (500MHz, CDCl3) δ1.93–1.77(m,6H),1.76–1.60(m,6H),1.61–1.18(m,12H),1.16(s,9H),1.13(s,9H). 31 P NMR (162 MHz, CDCl3) δ 28.77. 11 B NMR (128 MHz, CDCl3) δ 87.12.
[0185]
[0186] Di(adamantan-1-yl)(pent-4-en-1-yl)phosphane (C 25 H 39 P). To a solution of di-tert-butylphosphane (5.00 g, 16.5 mmol) in THF (200 ml) was added at -30°C. n A 2.5 M solution of BuLi (6.81 ml, 17.0 mmol) in hexane. The solution was then stirred at room temperature for 60 minutes. The reaction was cooled down to -30 °C again and then a solution of 5-bromopent-1-ene (2.71 g, 18.2 mmol) in THF (10 ml) was slowly added. The mixture was then stirred at room temperature for 16 hours. All solvents were then removed under vacuum. The crude product was stirred in pentane (10 ml) for 30 minutes. The pure product (2.70 g, 44%) was obtained by filtration as a white solid and washed with pentane.1 H NMR (500MHz, CDCl3) δ5.96–5.70(m,1H),5.21–4.83(m,2H),2.18(q,J=7.2Hz,2H),1.95(br,6H) ,1.87(qd,J=13.5,12.1,7.5Hz,12H),1.73(br,12H),1.58(h,J=7.9Hz,2H),1.42–1.32(m,2H). 13 C NMR (126MHz, CDCl3) δ138.74, 114.58, 40.87 (d, J = 10.5Hz), 37.09, 35.81 (d, J = 20.5Hz) ), 35.38 (d, J = 13.3Hz), 30.32 (d, J = 26.5Hz), 28.65 (d, J = 7.8Hz), 16.04 (d, J = 18.6Hz). 31 P NMR (162 MHz, CDCl3) δ 25.59.
[0187]
[0188] (5-(9-borabicyclo[3.3.1]non-9-yl)pentyl)bis(adamantan-1-yl)phosphane (C 33 H 54 BrPB). Di(adamantan-1-yl)(pent-4-en-1-yl)phosphane (1.50 g, 4.05 mmol) and 9-BBN (0.50 g, 4.13 mmol) were mixed in dichloromethane (10 ml) and stirred at room temperature for 16 hours. All solvents were then removed under vacuum. The crude product was stirred in pentane (10 ml) for 30 minutes. The pure product (1.99 g, 100%) was obtained by filtration as a white solid and washed with cold pentane. 1 H NMR (500MHz, CDCl3) δ2.00–1.79(m,24H),1.73(br,18H),1.62–1.32(m,10H),1.28–1.11(m,2H). 13 C NMR (126MHz, CDCl3) δ40.87 (d, J = 10.6Hz), 37.12, 35.76 (d, J = 20.7Hz), 34.68 (d, J = 12. 7Hz), 33.14, 31.05 (m), 28.67 (d, J = 7.9Hz), 28.08, 24.20, 23.25, 16.51 (d, J = 18.5Hz). 31 P NMR (162 MHz, CDCl3) δ 26.19. 11B NMR (128 MHz, CDCl3) δ 87.55.
[0189] Polymerization Example of CO2 and Cyclohexene Oxide (CHO)
[0190] The polymerization of CO2 and cyclohexene oxide (CHO) was carried out in a stainless steel container. The catalyst was first dissolved in 100uL of epoxide at the respective epoxide / catalyst molar ratio. The container was then pressurized, isolated and heated at various temperatures using 450psi CO2 for 12 hours. The reaction was then returned to ambient temperature and the pressure was reduced. The reaction mixture was then dissolved in 1mL CDCl3 containing 1,3-bis(trimethylsilyl)benzene (5mM) as an internal standard for quantification. 1 H NMR spectroscopy determines the turnover number (TON), which corresponds to the number of epoxides converted to polymer per catalyst. The polymer is isolated by drying in a vacuum oven. The molecular weight is determined by the GPC method using a dn / dc value of 0.089 mL / g.
[0191] Table 1: Examples of polymerization of CO2 and cyclohexene oxide (CHO)
[0192]
[0193]
[0194] a Footnote: Molecular weight not determined
[0195] Polymerization Example of β-Butyrolactone (BBL)
[0196] The polymerization of β-butyrolactone (BBL) was carried out in a stainless steel container. The catalyst was first dissolved in 100uL of epoxide at the respective monomer / catalyst molar ratio. Then, the container was isolated and heated at the respective temperature for 12 hours. The reaction was then returned to ambient temperature. The reaction mixture was then dissolved in 1mL CDCl3 containing 1,3-bis(trimethylsilyl)benzene (5mM) as an internal standard for quantification. 1 H NMR spectroscopy determined the turnover number (TON), which corresponds to the amount of β-butyrolactone converted to polymer per catalyst. The polymer was isolated by drying in a vacuum oven.
[0197] Table 2: β-Butyrolactone (BBL) polymerization example
[0198]
[0199] a Footnote: Molecular weight not determined
[0200] Polymerization Example in Parr Reactor
[0201] Synthesis of polycyclohexene carbonate (PCHC, EXP-AG8870). A Parr reactor was charged with catalyst 2 (133 mg), cyclohexene oxide CHO (40 mL) and trans-1,2-dihydroxycyclohexane DHCH (45.9 mg). The reactor was then pressurized with a steady-state CO2 pressure of 500 psi and heated at 90°C for 5 hours. The polymerization was stopped by cooling to ambient temperature, after which the CO2 was released. An aliquot was taken for 1 H NMR analysis (CDCl3) showed 86.5% conversion of cyclohexene oxide to polycyclohexene carbonate. Approximately 120 mL of dichloromethane was added. The mixture was transferred to a large beaker and all volatiles were removed under reduced pressure at 90°C to produce a white solid. The solid was further washed with methanol and dried under vacuum at 90°C to produce 46 g of polymer.
[0202] Other Implementations
[0203] Exemplary polymerization conditions include polymerization temperatures between 100°C and 180°C.
[0204] The feed may comprise carbon dioxide at a temperature greater than or equal to 31°C and a pressure of at least 1,070 psig.
[0205] The oxygenated polymer produced by the exemplary methods described above may include polymers having a polyether content of less than 15 wt. %, as measured by proton NMR spectroscopy.
[0206] In an exemplary embodiment, the feed can comprise a lactone, wherein the lactone is an enantiomerically enriched chiral lactone, preferably a chiral lactone having an enantiomeric ratio greater than or equal to 60:40.
[0207] In exemplary embodiments, the oxygen-containing polymer produced by the exemplary methods described above may comprise a polyester having from 0.1 to 2.0 olefinic end groups per polymer chain.
[0208] The exemplary embodiments described above may also include obtaining less than 15 wt % cis- and trans-crotonic acid as a co-product.
[0209] All documents described herein are incorporated herein by reference, including any priority documents and / or test procedures, as long as they do not contradict this article. As is apparent from the above general description and specific embodiments, although the form of the present invention has been described and described, various changes can be made without departing from the spirit and scope of the present invention. Therefore, it is not intended to limit the present invention thereby. Similarly, the term "comprising" is considered to be synonymous with the term "including". Similarly, whenever, a composition, an element or a group of elements is preceded by the conjunction "comprising", it should be understood that we also consider the same composition or element group with the conjunction "essentially consisting of...", "consisting of...", "selected from a group consisting of..." or "is" in front of the record of the composition, one or more elements, and vice versa.
Claims
1. A polymerization method comprising: contacting a feed comprising at least one oxygen-containing monomer with a catalyst system under polymerization conditions, and obtaining an oxygen-containing polymer, the catalyst system comprising a catalyst compound of formula (I), an optional co-activator and an optional chain transfer agent, in The feed comprises: at least one epoxide and one or more of CO2, COS, CS2, or at least one epoxide and at least one cyclic anhydride, or at least one lactone or at least one lactide; and The catalyst compound is represented by formula (I), in, B* is a Group 13 element, preferably boron or aluminum, or more preferably boron, P constitutes a tertiary phosphine structure, where P, Y, R 3 and R 4 covalently bonded, and P is not directly bonded to more than two nitrogen atoms, R 1 , R 2 , R 3 and R 4 wherein each is independently a hydrocarbyl group, a non-halogenated substituted hydrocarbyl group or a heteroatom-containing group, R 1 , R 2 , R 3 and R 4 wherein each may optionally contain a trisubstituted borane or trisubstituted phosphine moiety, R 1 and R 2 , R 3 and R 4 , R 1 and Y, R 3 and Y, R 1 and R 3 , and R 1 and R 2 and R 3 optionally fused to form a cyclic or polycyclic ring, and Y is a non-halogenated linking group having 1 to 50 non-hydrogen atoms, preferably 2 to 40 non-hydrogen atoms, more preferably 3 to 10 non-hydrogen atoms, preferably trimethylene, tetramethylene, pentamethylene, hexamethylene, heptamethylene, octamethylene, -CH2CH2Si(Me2)-CH2CH2- or -CH2(C6H4)-CH2-.
2. The method of claim 1, wherein the feed comprises one or more epoxide monomers and one or more of CO2, COS, CS2, and the oxygen-containing polymer comprises a polyalkylene carbonate or a polyalkylene ether carbonate.
3. The process of claim 1, wherein the feed comprises one or more epoxide monomers and one or more cyclic anhydrides, and the oxygen-containing polymer comprises a poly(epoxide)(cyclic anhydride) or a poly(epoxide)(cyclic anhydride) ether.
4. The process of claim 1, wherein the feed comprises one or more lactone or lactide monomers and the oxygen-containing polymer comprises a polyester polymer.
5. The method of claim 1, wherein B* is boron and R 1 and R 2 It forms a fused ring with B*, preferably 9-borahertabicyclo(3.3.1)nonane.
6. The method according to claim 1, wherein each R 3 and R 4 is a secondary alkyl group or a tertiary alkyl group, and R 3 and R 4 Optionally fused to form cyclic or polycyclic rings.
7. A method according to any preceding claim, wherein Y is a bridging group comprising at least one Group 13, 14, 15 or 16 element.
8. The method of claim 1, wherein Y is ER y 2 or (ER y 2)2, where E is C, Si or Ge, where each R y are independently hydrogen, halogen, C1-C 20 Hydrocarbon or C1-C 20 non-halogenated substituted hydrocarbon group, and both R y Cyclic structures may optionally be formed, including aromatic, partially saturated or saturated cyclic or fused ring systems.
9. The method according to claim 1, wherein Y is of the formula -(CH2) n - a connecting group, wherein n=3-8, preferably n=4-6, preferably n=5.
10. The method according to claim 1, wherein R 1 , R 2 , R 3 and R 4 Each of which is a hydrocarbyl group.
11. The method of claim 1, wherein the catalyst compound is one or more of the following: 。 12. The process according to claims 1 to 4, wherein a chain transfer agent is used and is one or more of: an alcohol, a carboxylic acid or a polymer containing at least one hydroxyl group or a carboxylic acid group.
13. The process according to claims 1 to 4, wherein a co-activator is used and the co-activator is one or more of the following: triethylborane or 1,8-diazabicyclo(5.4.0)undec-7-ene.
14. The process of claims 1 to 4, wherein the feed comprises at least two oxygen-containing monomers introduced into the polymerization reaction simultaneously or sequentially over different time periods, and the oxygen-containing polymer comprises a random, gradient or block copolymer.
15. The process of claims 1 to 4, wherein the polymerization conditions comprise a polymerization temperature between 100°C and 180°C.
16. The process of claim 2, wherein the feed comprises carbon dioxide and at least one of cyclohexene oxide, vinyl cyclohexene oxide, vinyl cyclohexene dioxide, limonene oxide, limonene dioxide, ethylene oxide, propylene oxide, butylene oxide, glycidyl n-butyl ether, or epichlorohydrin.
17. The method of claim 15, wherein the feed comprises carbon dioxide and at least one of vinyl cyclohexene dioxide or limonene dioxide, and the oxygen-containing polymer comprises a polyalkylene carbonate polymer comprising pendant cyclic carbonate groups.
18. The process of claim 2, wherein the feed comprises carbon dioxide at a temperature greater than or equal to 31°C and a pressure of at least 1,070 psig.
19. The method of claim 2, wherein the oxygen-containing polymer comprises a polymer having a polyether content of less than 15 weight percent as measured by proton NMR spectroscopy.
20. The method of claim 2, wherein the method further comprises forming a cyclic carbonate.
21. The method of claim 3, wherein the epoxide is one or more of cyclohexene oxide, vinyl cyclohexene oxide, vinyl cyclohexene dioxide, limonene oxide, limonene dioxide, ethylene oxide, propylene oxide, butylene oxide, glycidyl n-butyl ether, or epichlorohydrin.
22. The method of claim 3, wherein the cyclic anhydride is one or more of: succinic anhydride, maleic anhydride, glutaric anhydride, phthalic anhydride, or carbolic anhydride.
23. The method of claim 4, wherein the lactone is one or more of: caprolactone, methyl caprolactone, or decanolactone.
24. The process of claim 4, wherein the feed comprises a lactone, wherein the lactone is an enantiomerically enriched chiral lactone, preferably a chiral lactone having an enantiomeric ratio greater than or equal to 60:
40.
25. The method of claim 4, wherein the lactone is β-butyrolactone.
26. The method of claim 24, wherein the oxygen-containing polymer comprises a polyether having from 0.1 to 2.0 olefinic end groups per polymer chain.
27. The method of claim 24, wherein the method further comprises obtaining less than 15 wt% cis- and trans-crotonic acid as a co-product.
28. A catalyst compound represented by formula (I): in, B* is a Group 13 element, preferably boron or aluminum, or more preferably boron, R 1 and R 2 Each of the following is independently a secondary alkyl group, preferably a C2-C 40 A secondary or tertiary alkyl group, preferably a C2–C 40 Tertiary alkyl, P constitutes a tertiary phosphine structure, where P, Y, R 3 and R 4 Covalent bonding, R 3 is a secondary alkyl, a substituted secondary alkyl, a tertiary alkyl or a substituted tertiary alkyl, and may optionally contain one or more trisubstituted borane or trisubstituted phosphine moieties, R 4 is a hydrocarbyl, substituted hydrocarbyl or heteroatom-containing group and may optionally contain one or more trisubstituted borane or trisubstituted phosphine moieties, R 1 and R 2 , R 3 and R 4 , R 3 and Y are optionally fused to form a cyclic or polycyclic ring, Y is a saturated linking group having 3 to 50 Group 14 atoms, preferably 3 to 40 Group 14 atoms, more preferably 3 to 10 Group 14 atoms, preferably trimethylene, tetramethylene, pentamethylene, hexamethylene, heptamethylene, octamethylene, -CH2CH2Si(Me2)-CH2CH2- or -CH2(C6H4)-CH2-, and R 1 , R 2 , R 3 , R 4 and Y does not contain Group 1 to 12 elements, except for optional hydrogen.
29. The catalyst compound of claim 28, wherein B* is boron and R 1 and R 2 It forms a fused ring with B*, preferably 9-borahertabicyclo(3.3.1)nonane.
30. The catalyst compound according to claim 28, wherein R 3 or R 4 At least one of them is a secondary alkyl group or a tertiary alkyl group, and R 3 and R 4 Optionally fused to form cyclic or polycyclic rings.
31. The catalyst compound of claim 28, wherein Y is ER y 2 or (ER y 2)2, where E is C, Si or Ge, where each R y are independently hydrogen, halogen, C1-C 20 Hydrocarbon or C1-C 20 substituted hydrocarbon group, and both R y Saturated cyclic or fused ring systems may optionally be formed.
32. The catalyst compound of claim 28, wherein Y is of the formula -(CH2) n - a connecting group, wherein n=3-8, preferably n=4-6, preferably n=5.
33. The catalyst compound according to claim 28, wherein R 1 , R 2 , R 3 and R 4 Each of which is a hydrocarbyl group.
34. The catalyst compound of claim 28, wherein the catalyst compound is one or more of:
